BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li JW, Wei L, Han Z, Chen Z. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019;852:68-76. [PMID: 30682335 DOI: 10.1016/j.ejphar.2019.01.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 Kwok ZH, Ni K, Jin Y. Extracellular Vesicle Associated Non-Coding RNAs in Lung Infections and Injury. Cells 2021;10:965. [PMID: 33919158 DOI: 10.3390/cells10050965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
3 Ali M, Pham A, Wang X, Wolfram J, Pham S. Extracellular vesicles for treatment of solid organ ischemia-reperfusion injury. Am J Transplant 2020;20:3294-307. [PMID: 32594616 DOI: 10.1111/ajt.16164] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
4 Ahmed L, Al-Massri K. New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases. Tissue Eng Regen Med 2022. [PMID: 35867309 DOI: 10.1007/s13770-022-00469-x] [Reference Citation Analysis]
5 Liu Y, Yang Y, Mou F, Zhu J, Li H, Zhao T, Zhao Y, Shao S, Cui G, Guo H, Chen SY. Exosome-Mediated miR-21 Was Involved in the Promotion of Structural and Functional Recovery Effect Produced by Electroacupuncture in Sciatic Nerve Injury. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/7530102] [Reference Citation Analysis]
6 Sanie-Jahromi F, NejatyJahromy Y, Jahromi RR. A Review on the Role of Stem Cells against SARS-CoV-2 in Children and Pregnant Women. Int J Mol Sci 2021;22:11787. [PMID: 34769218 DOI: 10.3390/ijms222111787] [Reference Citation Analysis]
7 Azhdari MH, Goodarzi N, Doroudian M, MacLoughlin R. Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery. Int J Mol Sci 2022;23:6273. [PMID: 35682948 DOI: 10.3390/ijms23116273] [Reference Citation Analysis]
8 Zhang B, Tian X, Hao J, Xu G, Zhang W. Mesenchymal Stem Cell-Derived Extracellular Vesicles in Tissue Regeneration. Cell Transplant. 2020;29:963689720908500. [PMID: 32207341 DOI: 10.1177/0963689720908500] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
9 Xia X, Yuan P, Liu Y, Wang Y, Cao W, Zheng JC. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword? Immunology 2021;163:416-30. [PMID: 33742451 DOI: 10.1111/imm.13329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 You J, Fu Z, Zou L. Mechanism and Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells for the Treatment of Infectious Diseases. Front Microbiol 2021;12:761338. [PMID: 34764947 DOI: 10.3389/fmicb.2021.761338] [Reference Citation Analysis]
11 Huo W, Li Y, Zhang Y, Li H. Mesenchymal stem cells-derived exosomal microRNA-21-5p downregulates PDCD4 and ameliorates erectile dysfunction in a rat model of diabetes mellitus. FASEB J 2020;34:13345-60. [PMID: 32808325 DOI: 10.1096/fj.202000102RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Guo H, Su Y, Deng F. Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives. Stem Cell Rev Rep 2021;17:440-58. [PMID: 33211245 DOI: 10.1007/s12015-020-10085-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shen D, He Z. Mesenchymal stem cell-derived exosomes regulate the polarization and inflammatory response of macrophages via miR-21-5p to promote repair after myocardial reperfusion injury. Ann Transl Med 2021;9:1323. [PMID: 34532460 DOI: 10.21037/atm-21-3557] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ke X, Liao Z, Luo X, Chen J, Deng M, Huang Y, Wang Z, Wei M. Endothelial colony-forming cell-derived exosomal miR-21-5p regulates autophagic flux to promote vascular endothelial repair by inhibiting SIPL1A2 in atherosclerosis. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00828-0] [Reference Citation Analysis]
15 C. Rodriguez H, Gupta M, Cavazos-escobar E, Montalvo E, F. El-amin S, Gupta A. Mesenchymal Stem Cells and Extracellular Vesicles: An Emerging Alternative to Combat COVID-19. Biotechnology to Combat COVID-19 [Working Title]. IntechOpen; 2021. [DOI: 10.5772/intechopen.97212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhang TR, Huang WQ. Angiogenic Exosome-Derived microRNAs: Emerging Roles in Cardiovascular Disease. J Cardiovasc Transl Res 2021;14:824-40. [PMID: 33104961 DOI: 10.1007/s12265-020-10082-9] [Reference Citation Analysis]
17 Panda B, Sharma Y, Gupta S, Mohanty S. Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine: A Comprehensive Review. Life (Basel) 2021;11:784. [PMID: 34440528 DOI: 10.3390/life11080784] [Reference Citation Analysis]
18 Wang L, Chen B, Xiong X, Chen S, Jin L, Zhu M. Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats. Mediators Inflamm 2020;2020:7059304. [PMID: 33162831 DOI: 10.1155/2020/7059304] [Reference Citation Analysis]
19 Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, Gangemi S. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models. Int J Mol Sci 2019;20:E3938. [PMID: 31412612 DOI: 10.3390/ijms20163938] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
20 Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, Beheshtkhoo N, Kouhbanani MAJ, Marofi F, Nikoo M, Jarahian M. Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther 2021;12:297. [PMID: 34020704 DOI: 10.1186/s13287-021-02378-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 Ritiu SA, Rogobete AF, Sandesc D, Bedreag OH, Papurica M, Popovici SE, Toma D, Ivascu RI, Velovan R, Garofil DN, Corneci D, Bratu LM, Pahontu EM, Pistol A. The Impact of General Anesthesia on Redox Stability and Epigenetic Inflammation Pathways: Crosstalk on Perioperative Antioxidant Therapy. Cells 2022;11:1880. [PMID: 35741011 DOI: 10.3390/cells11121880] [Reference Citation Analysis]
22 Ma X, Huang M, Zheng M, Dai C, Song Q, Zhang Q, Li Q, Gu X, Chen H, Jiang G, Yu Y, Liu X, Li S, Wang G, Chen H, Lu L, Gao X. ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer's disease. J Control Release 2020;327:688-702. [PMID: 32931898 DOI: 10.1016/j.jconrel.2020.09.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
23 Wang B, Yu P, Lin W, Zhai Z. MicroRNA-21-5p Reduces Hypoxia/Reoxygenation-Induced Neuronal Cell Damage through Negative Regulation of CPEB3. Anal Cell Pathol (Amst) 2021;2021:5543212. [PMID: 34900520 DOI: 10.1155/2021/5543212] [Reference Citation Analysis]
24 Narang P, Shah M, Beljanski V. Exosomal RNAs in diagnosis and therapies. Non-coding RNA Research 2022;7:7-15. [DOI: 10.1016/j.ncrna.2022.01.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. Int Immunopharmacol 2021;101:108217. [PMID: 34627083 DOI: 10.1016/j.intimp.2021.108217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
26 Zhang F, Lu Y, Wang M, Zhu J, Li J, Zhang P, Yuan Y, Zhu F. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B. Mol Cell Probes 2020;51:101513. [PMID: 31968218 DOI: 10.1016/j.mcp.2020.101513] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 Suksatan W, Chupradit S, Yumashev AV, Ravali S, Shalaby MN, Mustafa YF, Kurochkin A, Siahmansouri H. Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. International Immunopharmacology 2021;101:108217. [DOI: 10.1016/j.intimp.2021.108217] [Reference Citation Analysis]
28 Tieu A, Stewart DJ, Lalu MM. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Good Things Come in Small Packages. Crit Care Med 2020;48:1095-7. [PMID: 32568911 DOI: 10.1097/CCM.0000000000004368] [Reference Citation Analysis]
29 Dauletova M, Hafsan H, Mahhengam N, Zekiy AO, Ahmadi M, Siahmansouri H. Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study. Clin Immunol 2021;226:108712. [PMID: 33684527 DOI: 10.1016/j.clim.2021.108712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Mahmoudi M, Taghavi-Farahabadi M, Namaki S, Baghaei K, Rayzan E, Rezaei N, Hashemi SM. Exosomes derived from mesenchymal stem cells improved function and survival of neutrophils from severe congenital neutropenia patients in vitro. Hum Immunol 2019;80:990-8. [PMID: 31706743 DOI: 10.1016/j.humimm.2019.10.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
31 Cai B, Yang L, Do Jung Y, Zhang Y, Liu X, Zhao P, Li J, Carvalho VF. PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-26. [DOI: 10.1155/2022/4512503] [Reference Citation Analysis]
32 Zoulikha M, Huang F, Wu Z, He W. COVID-19 inflammation and implications in drug delivery. J Control Release 2022;346:260-74. [PMID: 35469984 DOI: 10.1016/j.jconrel.2022.04.027] [Reference Citation Analysis]
33 Hajinejad M, Sahab-Negah S. Neuroinflammation: The next target of exosomal microRNAs derived from mesenchymal stem cells in the context of neurological disorders. J Cell Physiol 2021. [PMID: 34189724 DOI: 10.1002/jcp.30495] [Reference Citation Analysis]
34 Kiaie N, Ghanavati SPM, Miremadi SS, Hadipour A, Aghdam RM. Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence. Int J Stem Cells 2021;14:252-61. [PMID: 34158414 DOI: 10.15283/ijsc20182] [Reference Citation Analysis]
35 Xu HK, Chen LJ, Zhou SN, Li YF, Xiang C. Multifunctional role of microRNAs in mesenchymal stem cell-derived exosomes in treatment of diseases. World J Stem Cells 2020; 12(11): 1276-1294 [PMID: 33312398 DOI: 10.4252/wjsc.v12.i11.1276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
36 Wang MY, Zhou TY, Zhang ZD, Liu HY, Zheng ZY, Xie HQ. Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. MedComm (2020) 2021;2:351-80. [PMID: 34766151 DOI: 10.1002/mco2.74] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Gurunathan S, Kang MH, Kim JH. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments. Front Immunol 2021;12:716407. [PMID: 34394121 DOI: 10.3389/fimmu.2021.716407] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Deng H, Zhu L, Zhang Y, Zheng L, Hu S, Zhou W, Zhang T, Xu W, Chen Y, Zhou H, Li Q, Wei J, Yang H, Lv X, Saretzki G. Differential Lung Protective Capacity of Exosomes Derived from Human Adipose Tissue, Bone Marrow, and Umbilical Cord Mesenchymal Stem Cells in Sepsis-Induced Acute Lung Injury. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/7837837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Pu X, Ma S, Gao Y, Xu T, Chang P, Dong L. Mesenchymal Stem Cell-Derived Exosomes: Biological Function and Their Therapeutic Potential in Radiation Damage. Cells 2020;10:E42. [PMID: 33396665 DOI: 10.3390/cells10010042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Wang J, Xia J, Huang R, Hu Y, Fan J, Shu Q, Xu J. Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization. Stem Cell Res Ther 2020;11:424. [PMID: 32993783 DOI: 10.1186/s13287-020-01937-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
41 Wang X, Pham A, Kang L, Walker SA, Davidovich I, Iannotta D, TerKonda SP, Shapiro S, Talmon Y, Pham S, Wolfram J. Effects of Adipose-Derived Biogenic Nanoparticle-Associated microRNA-451a on Toll-like Receptor 4-Induced Cytokines. Pharmaceutics 2021;14:16. [PMID: 35056912 DOI: 10.3390/pharmaceutics14010016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Abreu SC, Lopes-Pacheco M, Weiss DJ, Rocco PRM. Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives. Front Cell Dev Biol 2021;9:600711. [PMID: 33659247 DOI: 10.3389/fcell.2021.600711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
43 Wang S, Lei B, Zhang E, Gong P, Gu J, He L, Han L, Yuan Z. Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. IJN 2022;Volume 17:1757-81. [DOI: 10.2147/ijn.s355366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Tieu A, Hu K, Gnyra C, Montroy J, Fergusson DA, Allan DS, Stewart DJ, Thébaud B, Lalu MM. Mesenchymal stromal cell extracellular vesicles as therapy for acute and chronic respiratory diseases: A meta-analysis. J Extracell Vesicles 2021;10:e12141. [PMID: 34596349 DOI: 10.1002/jev2.12141] [Reference Citation Analysis]
45 Harrell CR, Jovicic N, Djonov V, Volarevic V. Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes: From Basic Science to Clinics. Pharmaceutics 2020;12:E474. [PMID: 32456070 DOI: 10.3390/pharmaceutics12050474] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
46 Ramírez-hernández AA, Velázquez-enríquez JM, Santos-álvarez JC, López-martínez A, Reyes-jiménez E, Carrasco-torres G, González-garcía K, Vásquez-garzón VR, Baltierrez-hoyos R. The Role of Extracellular Vesicles in Idiopathic Pulmonary Fibrosis Progression: An Approach on Their Therapeutics Potential. Cells 2022;11:630. [DOI: 10.3390/cells11040630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Edalati S, Khajeniazi S. An Overview of Chemical and Biological Materials lead to Damage and Repair of Heart Tissue. Cardiovasc Eng Technol 2021. [PMID: 34046843 DOI: 10.1007/s13239-021-00544-9] [Reference Citation Analysis]
48 Mahajan A, Bhattacharyya S. A brief review on potential application of mesenchymal stem cell and secretome in combating mortality and morbidity in COVID-19 patients. Biomed J 2021;44:63-73. [PMID: 33727050 DOI: 10.1016/j.bj.2020.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
49 Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04096-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Go H, Maeda H, Miyazaki K, Maeda R, Kume Y, Namba F, Momoi N, Hashimoto K, Otsuru S, Kawasaki Y, Hosoya M, Dennery PA. Extracellular vesicle miRNA-21 is a potential biomarker for predicting chronic lung disease in premature infants. Am J Physiol Lung Cell Mol Physiol 2020;318:L845-51. [PMID: 32191117 DOI: 10.1152/ajplung.00166.2019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Qin S, Wang H, Liu G, Mei H, Chen M. miR‑21‑5p ameliorates hyperoxic acute lung injury and decreases apoptosis of AEC II cells via PTEN/AKT signaling in rats. Mol Med Rep 2019;20:4953-62. [PMID: 31702805 DOI: 10.3892/mmr.2019.10779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
52 Izadi M, Dehghan Marvast L, Rezvani ME, Zohrabi M, Aliabadi A, Mousavi SA, Aflatoonian B. Mesenchymal Stem-Cell Derived Exosome Therapy as a Potential Future Approach for Treatment of Male Infertility Caused by Chlamydia Infection. Front Microbiol 2021;12:785622. [PMID: 35095800 DOI: 10.3389/fmicb.2021.785622] [Reference Citation Analysis]
53 Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases. Cells. 2019;8. [PMID: 31835680 DOI: 10.3390/cells8121605] [Cited by in Crossref: 105] [Cited by in F6Publishing: 113] [Article Influence: 35.0] [Reference Citation Analysis]
54 Jansing JC, Fiedler J, Pich A, Viereck J, Thum T, Mühlfeld C, Brandenberger C. miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury. Int J Mol Sci 2020;21:E822. [PMID: 32012801 DOI: 10.3390/ijms21030822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
55 Su Y, Guo H, Liu Q. Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives. J Leukoc Biol 2021;110:27-38. [PMID: 33955590 DOI: 10.1002/JLB.3MR0321-545RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Wu Y, Zhang Z, Li J, Zhong H, Yuan R, Deng Z, Wu X. Mechanism of Adipose-Derived Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miR-21-5p in Hyperoxia-Induced Lung Injury. Stem Cell Rev Rep 2021. [PMID: 34882302 DOI: 10.1007/s12015-021-10311-x] [Reference Citation Analysis]
57 Diao L, Zhang Q. Transfer of lncRNA UCA1 by hUCMSCs-derived exosomes protects against hypoxia/reoxygenation injury through impairing miR-143-targeted degradation of Bcl-2. Aging (Albany NY) 2021;13:5967-85. [PMID: 33591946 DOI: 10.18632/aging.202520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Liu G, Qian M, Chen M, Chen T, Qin S. miR-21-5p Suppresses Mitophagy to Alleviate Hyperoxia-Induced Acute Lung Injury by Directly Targeting PGAM5. Biomed Res Int 2020;2020:4807254. [PMID: 33681349 DOI: 10.1155/2020/4807254] [Reference Citation Analysis]
59 Chen G, Wang M, Ruan Z, Zhu L, Tang C. Mesenchymal stem cell-derived exosomal miR-143-3p suppresses myocardial ischemia-reperfusion injury by regulating autophagy. Life Sci 2021;280:119742. [PMID: 34166712 DOI: 10.1016/j.lfs.2021.119742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9:28-38. [PMID: 31647191 DOI: 10.1002/sctm.19-0205] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
61 Li Y, Ye Z, Yang W, Zhang Q, Zeng J. An Update on the Potential of Mesenchymal Stem Cell Therapy for Cutaneous Diseases. Stem Cells Int 2021;2021:8834590. [PMID: 33505474 DOI: 10.1155/2021/8834590] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Cai J, Gehrau R, Tu Z, Leroy V, Su G, Shang J, Mas VR, Emtiazjoo A, Pelaez A, Atkinson C, Machuca T, Upchurch GR Jr, Sharma AK. MicroRNA-206 antagomiR‒enriched extracellular vesicles attenuate lung ischemia‒reperfusion injury through CXCL1 regulation in alveolar epithelial cells. J Heart Lung Transplant 2020;39:1476-90. [PMID: 33067103 DOI: 10.1016/j.healun.2020.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Caretti A, Peli V, Colombo M, Zulueta A. Lights and Shadows in the Use of Mesenchymal Stem Cells in Lung Inflammation, a Poorly Investigated Topic in Cystic Fibrosis. Cells 2019;9:E20. [PMID: 31861724 DOI: 10.3390/cells9010020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
64 Xiao K, He W, Guan W, Hou F, Yan P, Xu J, Zhou T, Liu Y, Xie L. Mesenchymal stem cells reverse EMT process through blocking the activation of NF-κB and Hedgehog pathways in LPS-induced acute lung injury. Cell Death Dis 2020;11:863. [PMID: 33060560 DOI: 10.1038/s41419-020-03034-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
65 Pinky, Gupta S, Krishnakumar V, Sharma Y, Dinda AK, Mohanty S. Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19. Stem Cell Rev Rep 2021;17:33-43. [PMID: 32661867 DOI: 10.1007/s12015-020-10002-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 23.0] [Reference Citation Analysis]
66 Shang S, Wang J, Chen S, Tian R, Zeng H, Wang L, Xia M, Zhu H, Zuo C. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Cancer Med. 2019;8:7728-7740. [PMID: 31642612 DOI: 10.1002/cam4.2633] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 8.7] [Reference Citation Analysis]
67 Planat-Benard V, Varin A, Casteilla L. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism. Front Immunol 2021;12:626755. [PMID: 33995350 DOI: 10.3389/fimmu.2021.626755] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Liu C, Xiao K, Xie L. Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment. Front Immunol 2022;13:928134. [DOI: 10.3389/fimmu.2022.928134] [Reference Citation Analysis]
69 Xu B, Chen SS, Liu MZ, Gan CX, Li JQ, Guo GH. Stem cell derived exosomes-based therapy for acute lung injury and acute respiratory distress syndrome: A novel therapeutic strategy. Life Sci 2020;254:117766. [PMID: 32418895 DOI: 10.1016/j.lfs.2020.117766] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
70 Shi W, Guo S, Liu L, Liu Q, Huo F, Ding Y, Tian W. Small Extracellular Vesicles from Lipopolysaccharide-Preconditioned Dental Follicle Cells Promote Periodontal Regeneration in an Inflammatory Microenvironment. ACS Biomater Sci Eng 2020;6:5797-810. [PMID: 33320548 DOI: 10.1021/acsbiomaterials.0c00882] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
71 Xie K, Liu L, Chen J, Liu F. Exosomes derived from human umbilical cord blood mesenchymal stem cells improve hepatic ischemia reperfusion injury via delivering miR-1246. Cell Cycle. 2019;18:3491-3501. [PMID: 31709894 DOI: 10.1080/15384101.2019.1689480] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
72 Thomas SC, Kim JW, Pauletti GM, Hassett DJ, Kotagiri N. Exosomes: Biological Pharmaceutical Nanovectors for Theranostics. Front Bioeng Biotechnol 2021;9:808614. [PMID: 35096795 DOI: 10.3389/fbioe.2021.808614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Moghadasi S, Elveny M, Rahman HS, Suksatan W, Jalil AT, Abdelbasset WK, Yumashev AV, Shariatzadeh S, Motavalli R, Behzad F, Marofi F, Hassanzadeh A, Pathak Y, Jarahian M. A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine. J Transl Med 2021;19:302. [PMID: 34253242 DOI: 10.1186/s12967-021-02980-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
74 Xie K, Liu L, Chen J, Liu F. Exosomal miR-1246 derived from human umbilical cord blood mesenchymal stem cells attenuates hepatic ischemia reperfusion injury by modulating T helper 17/regulatory T balance. IUBMB Life 2019;71:2020-30. [PMID: 31433911 DOI: 10.1002/iub.2147] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
75 Lu K, Chen Q, Li M, He L, Riaz F, Zhang T, Li D. Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer. Free Radic Biol Med 2020;159:150-63. [PMID: 32745771 DOI: 10.1016/j.freeradbiomed.2020.06.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]